WASHINGTON -- A representative for former President Joe Biden said he last took a prostate-specific antigen blood test, commonly used to screen for prostate cancer, in 2014. Although the exact ...

Dr. Abhay Moghekar, associate professor of neurology at Johns Hopkins, whose lab was involved in evaluating the blood test for FDA approval, said this will help avoid unnecessary tests and get the ...

The test measures two proteins that are linked to amyloid plaques in the brain, which are among the hallmarks of Alzheimer's. Trump orders Walmart to ‘eat the tariffs’ and stop blaming his ...

The agency added that the risks associated with the blood test are mainly the risk of a false positive or false negative test result. Preventive neurologist Dr. Richard Isaacson, who established ...

(AP Photo/Evan Vucci, File) WASHINGTON (AP) — U.S. health officials on Friday endorsed the first blood test that can help diagnose Alzheimer ... for U.S. patients earlier in the disease,” said Dr.

WASHINGTON — U.S. health officials on Friday endorsed the first blood test that can help diagnose ... patients earlier in the disease,” said Dr. Michelle Tarver, of FDA’s center for devices.

The Food and Drug Administration (FDA) announced Friday it had cleared a new test to help diagnose adults with Alzheimer’s disease, the first diagnostic tool that uses a blood draw to check for ...

The first blood test used to diagnose Alzheimer’s disease was cleared by the Food and Drug Administration for marketing Friday, meaning the laboratory test can be marketed and sold in the U.S ...

The Food and Drug Administration has greenlit Japan-based test manufacturer Fujirebio to begin marketing its blood test for helping ... earlier in the disease," Dr. Michelle Tarver, director ...

The FDA said it has issued its first official green light for a blood test to help diagnose Alzheimer’s disease, adding that it can help reduce the need for invasive samples or expensive PET scans.

"This blood test will allow primary care providers to start the diagnostic process, which is meaningful because patients typically wait months to be evaluated by a neurologist," Dr. Leah Croll ...